Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline

Cilt: 37 Sayı: 1 31 Ekim 2011
PDF İndir

Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline

Öz

A case of fibroepithelial mammary hyperplasia in a two years old, intact, tabby female cat that showed oestrus 1 month ago was treated with the combination of aglepristone (Alizine, Virbac®)  and cabergoline (Galastop, Ceva®) administrations. On the day of treatment, serum progesterone concentration was detected as 2,96 ng/ml and serum oestradiol concentration was below 5,0 pg/ml. The cat was treated with subcutaneous (SC) injections of aglepristone (Alizine, Virbac®) 15 mg/kg body weight (b.w.) on two subsequent days per week for three weeks and 5 µg/kg b.w per a day, per os (PO) cabergoline (Galastop, Ceva®) administration was accompanied to this treatment on the first week for seven days. On the examination at the end of the third week, there was a marked regression of the mammary glands and the milk secretion ceased. Six weeks after the initiation of treatment, mammary glands were completely regressed and serum progesterone and oestradiol concentrations were 0.142 ng/ml, and <5pg/ml respectively. It is determined that in such cases which is associated with milk secretion, successful results can be achieved by using aglepristone (Alizine, Virbac®) and cabergoline (Galastop, Ceva®)  together.

Key Words: Fibroepithelial hyperplasia, aglepristone, cabergoline

Anahtar Kelimeler

Kaynakça

  1. Allen, H., 1973. Feline mammary hypertrophy. Veterinary Pathology 10, 501-508.
  2. Arbeiter, K., Brass, W., Ballabio, R., Jöchle, W., 1998. Treatment of pseudopregnancy in the bitch with cabergoline, an ergoline derivate. Journal of Small Animal Practice 29, 781-788.
  3. Baştan, A., Fındık, M., Erünal, N., Aslan, S., Kılıçoğlu, Ç., 1998. The use of cabergoline for the treatment of pseudopregnancy in dogs with the purpose of suppressing lactation. Reproduction in Domestic Animal 33,49-53.
  4. Baştan, A., Özenç, E . , Yağcı, İ.P., Beceriklisoy, H.B., 2004. Bir kedide meme hipertrofisi olgusu. Ankara Üniversitesi Veteriner Fakültesi Dergisi 51, 79-82.
  5. Bethlehem, M., Van der I, R.J.T., 1993. Feline fibro- epitheliale hyperplasie bij drie gecastreerde katers na behandeling met progestativa. Tijdschr Diergeneeskd. 118, 650-652.
  6. Treatment of Feline Mammary Fibroepithelial Hyperplasia with the
  7. Görlinger, S., Kooistra, H.S., Van den Broek, A., Okkens, A.C., 2002. Treatment of fibroadenomatous hyperplasia in cats with aglepristone. Journal of Veterinary Internal Medicine 16, 710-713.
  8. Johnston, S.D., Kustritz, M.V.R., Olson, P.N.S., 2001. Mammary hypertropy. In: Johnston, S.D., Kustritz, M.V.R., Olson, P.N.S. (Eds.), Canine and feline theriogenology. Philadelphia, W.B. Saunders Company, pp. 474-477.

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yayımlanma Tarihi

31 Ekim 2011

Gönderilme Tarihi

31 Ekim 2011

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2011 Cilt: 37 Sayı: 1

Kaynak Göster

APA
Uçmak, M., Enginler, S., Gündüz, M., Kırşan, İ., & Sönmez, K. (2011). Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. İstanbul Üniversitesi Veteriner Fakültesi Dergisi, 37(1), 69-74. https://doi.org/10.16988/iuvfd.12677
AMA
1.Uçmak M, Enginler S, Gündüz M, Kırşan İ, Sönmez K. Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. iuvfd. 2011;37(1):69-74. doi:10.16988/iuvfd.12677
Chicago
Uçmak, Melih, Sinem Enginler, Mehmet Gündüz, İsmail Kırşan, ve Kıvılcım Sönmez. 2011. “Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline”. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37 (1): 69-74. https://doi.org/10.16988/iuvfd.12677.
EndNote
Uçmak M, Enginler S, Gündüz M, Kırşan İ, Sönmez K (01 Ekim 2011) Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37 1 69–74.
IEEE
[1]M. Uçmak, S. Enginler, M. Gündüz, İ. Kırşan, ve K. Sönmez, “Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline”, iuvfd, c. 37, sy 1, ss. 69–74, Eki. 2011, doi: 10.16988/iuvfd.12677.
ISNAD
Uçmak, Melih - Enginler, Sinem - Gündüz, Mehmet - Kırşan, İsmail - Sönmez, Kıvılcım. “Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline”. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37/1 (01 Ekim 2011): 69-74. https://doi.org/10.16988/iuvfd.12677.
JAMA
1.Uçmak M, Enginler S, Gündüz M, Kırşan İ, Sönmez K. Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. iuvfd. 2011;37:69–74.
MLA
Uçmak, Melih, vd. “Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline”. İstanbul Üniversitesi Veteriner Fakültesi Dergisi, c. 37, sy 1, Ekim 2011, ss. 69-74, doi:10.16988/iuvfd.12677.
Vancouver
1.Melih Uçmak, Sinem Enginler, Mehmet Gündüz, İsmail Kırşan, Kıvılcım Sönmez. Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. iuvfd. 01 Ekim 2011;37(1):69-74. doi:10.16988/iuvfd.12677